- Report
- March 2024
- 188 Pages
Global
From €3242EUR$3,374USD£2,772GBP
€3602EUR$3,749USD£3,080GBP
- Report
- February 2024
- 175 Pages
Global
From €3843EUR$4,000USD£3,286GBP
- Report
- August 2023
- 119 Pages
Global
From €4708EUR$4,900USD£4,025GBP
- Report
- November 2021
- 256 Pages
Global
From €5044EUR$5,250USD£4,313GBP
- Report
- June 2022
- 203 Pages
Global
From €5044EUR$5,250USD£4,313GBP
- Report
- December 2018
- 438 Pages
Global
From €1321EUR$1,375USD£1,130GBP
€2642EUR$2,750USD£2,259GBP
- Report
- November 2022
- 65 Pages
Global
From €4756EUR$4,950USD£4,066GBP
- Report
- April 2021
Global
From €3060EUR$3,185USD£2,616GBP
€4372EUR$4,550USD£3,738GBP
- Book
- January 2022
- 400 Pages
Digital Biomanufacturing is a subset of biotechnology that focuses on the use of digital technologies to improve the efficiency and effectiveness of biomanufacturing processes. It involves the integration of digital technologies such as artificial intelligence, machine learning, and the Internet of Things (IoT) into biomanufacturing processes. This integration enables the automation of processes, the optimization of production, and the collection of data for analysis and decision-making. Digital Biomanufacturing also enables the development of new products and services, such as personalized medicines and cell therapies.
Companies in the Digital Biomanufacturing market include G-CON Manufacturing, Inc., Cytiva, Thermo Fisher Scientific, Merck KGaA, and GE Healthcare. Show Less Read more
